Aircall Unveils AI Voice Agent to Help Growing Businesses Handle Calls 24/7
In today’s fast-paced business landscape, every missed call is a missed opportunity. Aircall, the customer communications and intelligence platform trusted by over 20,000 growing businesses, today announces the launch of AI Voice Agent, an intelligent, always-on virtual assistant that ensures businesses never miss a call again. By answering inbound inquiries, handling frequently-asked questions (“FAQs”), and capturing caller details in real time, AI Voice Agent enables businesses to deliver seamless customer experiences without the overhead of large AI investments.
AI Voice Agent operates 24/7, ensuring customers can always connect with a representative, whether after hours, during peak call times, or amid seasonal surges. Unlike traditional AI-driven contact center solutions that require complex implementation, Aircall’s AI Voice Agent integrates seamlessly into its platform, helping businesses scale without adding operational burden.
Key features and benefits of AI Voice Agent
- Instant answers to common questions: AI Voice Agent learns from a business’s FAQs and autonomously responds to routine inquiries, reducing the workload on live teams and ensuring faster response times.
- Smart call qualification & handoff: For complex queries, AI Voice Agent gathers key caller details, ensuring sales and support teams have the necessary context for efficient follow-ups.
- Seamless integration: Businesses can plug AI Voice Agent into their call flows and pre-existing integrations on Aircall, so conversations handled by AI Agents can be easily tracked by your team.
- Effortless deployment, no IT required: AI Voice Agent is designed for ease of use, with a simple setup process that allows teams to start automating call handling within minutes.
- Flexible, cost-effective solution: With a pay-as-you-go model, AI Voice Agent makes AI-driven automation accessible to growing businesses without the heavy price tag of enterprise AI solutions.
“Missed calls don’t just mean lost revenue, they create frustration for both customers and teams,” said Tom Chen, Chief Product Officer at Aircall. “Sales teams lose potential deals when leads can’t reach them, and support teams struggle with backlogs when they’re stretched too thin. Aircall’s AI Voice Agent ensures every inquiry is addressed promptly, allowing teams to focus on the high-value conversations that drive growth and customer satisfaction.”
By eliminating missed calls and reducing wait times, AI Voice Agent empowers businesses to provide superior customer experiences while optimizing operational efficiency. This innovation aligns with Aircall’s mission to help sales and support teams have more meaningful conversations, without unnecessary complexity or cost.
Looking ahead to 2025, Aircall will expand AI Voice Agent’s capabilities with:
- Seamless call transfers: AI Voice Agent intelligently routes complex inquiries to live agents, providing full conversation context to ensure smooth handoffs.
- Deeper CRM & Helpdesk integrations: In addition to its current integration capabilities, further enhancements will enable customers to further automate post-call workflows, customer data entry, and more.
- Outbound call automation: Future enhancements will enable AI Voice Agent to proactively place follow-up calls, send reminders, and handle appointment scheduling.
“For many growing businesses, AI has been associated with complexity, requiring deep technical expertise and heavy upfront investment,” said Scott Chancellor, CEO of Aircall. “With AI Voice Agent, we’re redefining what’s possible, bringing intelligent automation to businesses in a way that’s intuitive, adaptive, and impactful. This is more than just handling calls; it’s about leveraging AI to empower teams, enrich customer conversations, and drive real business growth.”
The launch of AI Voice Agent marks another huge milestone in Aircall’s thriving AI technology development, building on the ongoing success of AI Assist. As part of its ongoing investment in AI-driven solutions, Aircall will soon introduce AI Assist Pro, a next-generation tool designed to enhance sales and support efficiency through real-time assistance and intelligent recommendations.
AI Voice Agent is available on April 15, 2025. Learn more at http://aircall.io/products/ai/voice-agent
About Aircall
Aircall is the world’s leading integrated customer communications and intelligence platform for growing businesses. Trusted by over 20,000 companies worldwide, Aircall unifies voice and digital channels into one seamless platform, offering one-click integrations with leading CRMs and over 100 business tools. With real-time, AI-powered insights and feedback, AI agents, and automation, we help sales and support teams save time on routine tasks, uncover opportunities, and deliver exceptional customer experiences. With a global team of 600+ across nine offices, Aircall is transforming how businesses connect with their customers, driving smarter conversations, deeper relationships, and measurable success.
https://aircall.io/
View source version on businesswire.com: https://www.businesswire.com/news/home/20250409246023/en/
Contacts
Media contact
Tara de Nicolas
tara.denicolas@aircall.io
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Announces Positive Topline Results for Sonrotoclax in Relapsed or Refractory Mantle Cell Lymphoma (MCL)29.8.2025 13:00:00 EEST | Press release
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from a Phase 1/2 study (BGB-11417-201) of sonrotoclax, a next-generation and potentially best-in-class investigational BCL2 inhibitor, in adult patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL), following treatment with a Bruton’s tyrosine kinase inhibitor (BTKi) and anti-CD20 therapy. BeOne plans to present the full data at an upcoming medical meeting. “For people with relapsed or refractory mantle cell lymphoma, the disease is aggressive, the treatment landscape fragmented, and the outcomes unacceptably poor. These topline results for sonrotoclax underscore its potential to deliver meaningful and durable responses and offer the first BCL2 inhibitor for patients with R/R MCL, if approved,” said Lai Wang, PhD, Global Head of R&D, BeOne Medicines. “These data add to the remarkable progress we’ve seen over the past five years in treating B-cel
Oulu2026 – European Capital of Culture: Oulu to Unveil Full European Capital of Culture 2026 Programme – Live Stream on 4 September 202529.8.2025 11:46:00 EEST | Press release
Hundreds of partners are creating a year in which Northern Finland becomes a new hub of culture. The programme will offer something for everyone: large-scale exhibitions, festivals across all genres, world premieres, performing arts, village celebrations, permanent artworks, sports, and community events across a vast region of 40 municipalities. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250829591577/en/ Oulu, with its 39 partner municipalities in Northern Finland, will step into the spotlight as European Capital of Culture 2026. The full programme will be officially launched on Thursday 4 September 2025 in Oulu, streamed live across Europe. The Oulu2026 programme is built around the theme of Cultural Climate Change, meaning a lasting enrichment of cultural life – connecting people through world-class experiences, creativity, and new ways of thinking. “2026 will be a transformative year – for our city, for Northern Finla
Nippon Sanso Holdings Group Unifies Global Brand Logo Launching the "NIPPON SANSO" Brand Worldwide29.8.2025 09:00:00 EEST | Press release
Nippon Sanso Holdings Corporation (President CEO: Toshihiko Hamada) will unify the brand logo for its industrial gas business globally and implement the change in stages. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828253560/en/ Until now, our group has operated industrial gas businesses worldwide using the same symbol mark, while adapting to each region. To further enhance recognition and understanding of our group as a unified entity among a broad range of stakeholders, and to maximize corporate value and achieve sustainable growth, we have decided to unify the brand for our industrial gas businesses as "NIPPON SANSO" and standardize the brand logo globally. Moving forward, we will continue striving to be a trusted company for all stakeholders as a globally recognized brand. *Please note that Thermos Group, which operates the consumer household goods business within our group, will not change its brand logo. *The log
TOM FORD Unveils Black Orchid Reserve Campaign Starring Tilda Swinton29.8.2025 07:35:00 EEST | Press release
The quest for exceptional rarity. Introducing Tilda Swinton for the new TOM FORD Black Orchid Reserve campaign. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250828507187/en/ “It is a profound honour for me to play a part in the history of TOM FORD’s legendary Black Orchid. Transformation, the blurring of boundaries and the celebration of magical properties have always drawn me close; Black Orchid Reserve is precisely such an enchantment.” — Tilda Swinton A celebrated actor and artist, Swinton is a singular presence known for her fearless artistry and transformative performances. An Academy Award, BAFTA and Golden Lion for Lifetime Achievement winner, Swinton defies conventions with elegance, intellect and a visionary approach to cinema. Her work transcends definition, shaping the culture through work in film, art and performance. TOM FORD creative director Haider Ackermann designed the campaign as a cinematic portrait of r
Novotech Supports Groundbreaking Approval of Anlotinib Combination Therapy for Advanced Soft Tissue Sarcoma28.8.2025 23:15:00 EEST | Press release
Novotech, a globally recognized full-service clinical research organization (CRO), is proud to have partnered with Chia Tai Tianqing Pharmaceutical Group Co., Ltd. (CTTQ Pharma) in achieving a significant regulatory milestone: the approval of Anlotinib Hydrochloride Capsules for a new indication as a first-line treatment for unresectable locally advanced or metastatic soft tissue sarcoma (STS) in combination with chemotherapy. This approval marks the ninth indication for Anlotinib in China and represents the world’s first official approval of an Anlotinib-chemotherapy combination for first-line treatment of advanced or metastatic STS. Previously recommended as a second-line monotherapy by the Chinese Society of Clinical Oncology (CSCO) guidelines, Anlotinib was the only Grade I targeted therapy for STS. This new indication represents a significant advancement for patients who have not previously received systemic treatment, expanding access to more effective and targeted first-line the
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom